Get the Stockscreener App
0.5832
0.59%
0.0034
After Hours:
.57
-0.0132
-2.26%
Lyell Immunopharma Inc Stock (LYEL) Forecast
The Lyell Immunopharma Inc (LYEL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.5929, representing a +687.54% increase from the current price of $0.5832. The highest analyst price target is $4.5191, and the lowest is $4.6668.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LYEL Price Target
Average 3.1328
(+437.17% Upside)
Is Lyell Immunopharma Inc (LYEL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.38 | Neutral |
| STOCH(9,6) | 47.67 | Neutral |
| STOCHRSI(14) | 59.37 | Neutral |
| MACD(12,26) | -0.0417 | Buy |
| ADX(14) | 21.83 | Neutral |
| William %R | -67.85 | Neutral |
| CCI(14) | -23.36 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5867
Sell
|
0.5954
Sell
|
| MA20 |
0.6106
Sell
|
0.6181
Sell
|
| MA50 |
0.745
Sell
|
0.7456
Sell
|
| MA100 |
0.9768
Sell
|
0.9643
Sell
|
| MA200 |
1.4783
Sell
|
1.2594
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, LYEL could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on LYEL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.38 indicates that LYEL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 47.67 indicates that LYEL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 59.37 indicates that LYEL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.83 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -23.36 indicates that LYEL is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LYEL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lyell Immunopharma Inc financial reports and earnings history, Lyell Immunopharma Inc (LYEL) stock could reach $6.4991 by 2030, $59.88 by 2040 and $90.83 by 2050. See the projected annual prices until 2050 of the Lyell Immunopharma Inc stock below:
- Lyell Immunopharma Inc (LYEL) is expected to reach an average price of $25.15 in 2035, with a high prediction of $26.11 and a low estimate of $26.12. This indicates an $4,212% rise from the last recorded price of $0.5832.
- Lyell Immunopharma Inc (LYEL) stock is projected to chart a bullish course in 2040, with an average price target of $60.07, representing an $10,200% surge from its current level. The forecast ranges from a conservative $7.9978 to a sky-high $59.88.
- Our analysts predict Lyell Immunopharma Inc (LYEL) to jump 7,069% by 2045, soaring from $41.99 to an average price of $41.81, potentially reaching $42.69. While $41.99 is the low estimate, the potential upside is significant.
- Lyell Immunopharma Inc (LYEL) stock is expected to climb by 2050, reaching an average of $88.97, a $15,155% jump from its current level. However, a wide range of estimates exists, with high and low targets of $90.83 and $89.51, respectively, highlighting the market's uncertainty.
Lyell Immunopharma Inc Stock (LYEL) Year by Year Forecast
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2025
Lyell Immunopharma Inc Stock (LYEL) is expected to reach an average price of $3.1328 in 2025, with a high prediction of $5.1102 and a low estimate of $1.1553. This indicates an +437.17% rise from the last recorded price of $0.5832.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $4.5867 | $4.6668 | $4.5191 | +686.48% |
| March, 2025 | $5.4202 | $4.6385 | $5.1102 | +829.39% |
| April, 2025 | $3.7496 | $4.5037 | $4.992 | +542.94% |
| May, 2025 | $2.2331 | $2.8414 | $2.3872 | +282.90% |
| June, 2025 | $1.4266 | $3.2566 | $2.7207 | +144.62% |
| July, 2025 | $1.496 | $1.5825 | $1.5301 | +156.51% |
| August, 2025 | $0.7895 | $1.4577 | $0.6118 | +35.37% |
| September, 2025 | $1.753 | $1.1553 | $1.2531 | +200.58% |
| October, 2025 | $3.3823 | $1.9438 | $3.0223 | +479.96% |
| November, 2025 | $4.0558 | $3.4482 | $3.4558 | +595.45% |
| December, 2025 | $3.9752 | $3.9693 | $3.9767 | +581.62% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2026
The predicted value for Lyell Immunopharma Inc (LYEL) in 2026 is set at an average of $3.1135. Estimates vary from a peak of $4.2863 to a trough of $1.9407, indicating an +433.87% surge from the present price of $0.5832.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8487 | $3.6278 | $3.5095 | +559.93% |
| February, 2026 | $4.2322 | $4.3022 | $4.2863 | +625.69% |
| March, 2026 | $3.8357 | $4.2057 | $4.1381 | +557.70% |
| April, 2026 | $3.3951 | $3.7325 | $3.6492 | +482.15% |
| May, 2026 | $2.4286 | $2.9386 | $3.131 | +316.42% |
| June, 2026 | $2.1021 | $2.6021 | $2.0345 | +260.44% |
| July, 2026 | $2.1015 | $2.2356 | $2.0038 | +260.33% |
| August, 2026 | $2.5449 | $2.1573 | $2.3499 | +336.38% |
| September, 2026 | $2.7743 | $2.2626 | $2.4145 | +375.71% |
| October, 2026 | $2.5678 | $2.8878 | $2.7111 | +340.30% |
| November, 2026 | $1.8113 | $2.4313 | $2.4737 | +210.58% |
| December, 2026 | $1.7207 | $1.9407 | $1.8698 | +195.04% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lyell Immunopharma Inc (LYEL) is $7.7606, with a high forecast of $15.48 and a low forecast of $0.0458. This indicates an +1,231% increase from the last price of $0.5832.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.4342 | $1.4692 | $1.4416 | +145.92% |
| February, 2027 | $1.0377 | $1.2359 | $1.0001 | +77.93% |
| March, 2027 | $0.4071 | $0.9171 | $1.0894 | -30.20% |
| April, 2027 | $0.3806 | $0.1797 | $0.6509 | -34.75% |
| May, 2027 | $0.7259 | $0.2241 | $0.8609 | +24.48% |
| June, 2027 | $10.15 | $0.0458 | $9.96 | +1,640% |
| July, 2027 | $7.967 | $8.9152 | $9.4317 | +1,266% |
| August, 2027 | $9.174 | $9.2587 | $11.66 | +1,473% |
| September, 2027 | $9.3827 | $9.7227 | $10.34 | +1,509% |
| October, 2027 | $13.47 | $9.6245 | $11.82 | +2,210% |
| November, 2027 | $13.93 | $13.72 | $12.75 | +2,288% |
| December, 2027 | $16.40 | $14.95 | $15.48 | +2,711% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2028
In 2028, Lyell Immunopharma Inc (LYEL) is projected to reach an average price of $12.45, with a high projection of $15.69 and a low estimate of $9.2107. This indicates an +2,035% rise from the last price of $0.5832.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $15.07 | $15.61 | $15.69 | +2,484% |
| February, 2028 | $14.08 | $13.98 | $14.00 | +2,314% |
| March, 2028 | $14.60 | $14.20 | $14.50 | +2,403% |
| April, 2028 | $14.32 | $14.47 | $14.16 | +2,355% |
| May, 2028 | $14.66 | $14.30 | $14.64 | +2,414% |
| June, 2028 | $11.63 | $12.89 | $13.62 | +1,894% |
| July, 2028 | $11.88 | $11.92 | $11.40 | +1,937% |
| August, 2028 | $10.10 | $10.21 | $11.53 | +1,631% |
| September, 2028 | $9.0337 | $9.8737 | $9.9702 | +1,449% |
| October, 2028 | $9.0407 | $9.2107 | $8.6972 | +1,450% |
| November, 2028 | $9.7894 | $9.4724 | $9.4377 | +1,579% |
| December, 2028 | $10.75 | $10.90 | $10.62 | +1,743% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2029
The 2029 price forecast for Lyell Immunopharma Inc Stock (LYEL) is $8.9904 on average, with a high prediction of $11.20 and a low estimate of $6.7824. This represents an +1,442% increase from the previous price of $0.5832.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.85 | $10.94 | $11.20 | +1,760% |
| February, 2029 | $10.46 | $10.93 | $10.65 | +1,694% |
| March, 2029 | $10.68 | $10.40 | $10.38 | +1,731% |
| April, 2029 | $10.79 | $10.75 | $10.80 | +1,749% |
| May, 2029 | $9.7749 | $9.7999 | $10.25 | +1,576% |
| June, 2029 | $9.1019 | $9.4619 | $9.5884 | +1,461% |
| July, 2029 | $7.6089 | $8.2439 | $8.4637 | +1,205% |
| August, 2029 | $7.5377 | $7.5509 | $7.3942 | +1,192% |
| September, 2029 | $7.0647 | $7.1347 | $7.1119 | +1,111% |
| October, 2029 | $6.9234 | $7.2534 | $7.1349 | +1,087% |
| November, 2029 | $7.3404 | $6.8551 | $7.1104 | +1,159% |
| December, 2029 | $6.7374 | $6.7824 | $7.0471 | +1,055% |
Lyell Immunopharma Inc Stock (LYEL) Price Forecast for 2030
Lyell Immunopharma Inc Stock (LYEL) is expected to reach an average price of $13.00 in 2030, with a high forecast of $24.08 and a low forecast of $1.9151. This signifies an +2,128% surge from the last price of $0.5832.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.7061 | $6.1061 | $6.4991 | +878.42% |
| February, 2030 | $5.2131 | $5.3231 | $5.5646 | +793.88% |
| March, 2030 | $4.5801 | $4.7196 | $4.6866 | +685.34% |
| April, 2030 | $4.2771 | $4.2821 | $4.1519 | +633.39% |
| May, 2030 | $2.5459 | $3.1059 | $4.0789 | +336.53% |
| June, 2030 | $3.0329 | $2.3976 | $2.7629 | +420.04% |
| July, 2030 | $2.1416 | $2.2016 | $2.5646 | +267.22% |
| August, 2030 | $22.11 | $1.9151 | $22.44 | +3,691% |
| September, 2030 | $18.53 | $21.20 | $20.16 | +3,077% |
| October, 2030 | $22.59 | $23.02 | $23.69 | +3,773% |
| November, 2030 | $20.93 | $21.21 | $21.25 | +3,488% |
| December, 2030 | $24.43 | $23.75 | $24.08 | +4,088% |
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):